JP2012518034A5 - - Google Patents

Download PDF

Info

Publication number
JP2012518034A5
JP2012518034A5 JP2011551028A JP2011551028A JP2012518034A5 JP 2012518034 A5 JP2012518034 A5 JP 2012518034A5 JP 2011551028 A JP2011551028 A JP 2011551028A JP 2011551028 A JP2011551028 A JP 2011551028A JP 2012518034 A5 JP2012518034 A5 JP 2012518034A5
Authority
JP
Japan
Prior art keywords
solution
injecting
chromatography column
daptomycin
subjecting
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2011551028A
Other languages
English (en)
Japanese (ja)
Other versions
JP5752609B2 (ja
JP2012518034A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/NO2010/000066 external-priority patent/WO2010095953A1/en
Publication of JP2012518034A publication Critical patent/JP2012518034A/ja
Publication of JP2012518034A5 publication Critical patent/JP2012518034A5/ja
Application granted granted Critical
Publication of JP5752609B2 publication Critical patent/JP5752609B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2011551028A 2009-02-19 2010-02-19 リポペプチドを精製する方法 Active JP5752609B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US15366009P 2009-02-19 2009-02-19
US61/153,660 2009-02-19
PCT/NO2010/000066 WO2010095953A1 (en) 2009-02-19 2010-02-19 Process for purifying lipopeptides

Publications (3)

Publication Number Publication Date
JP2012518034A JP2012518034A (ja) 2012-08-09
JP2012518034A5 true JP2012518034A5 (enExample) 2013-04-11
JP5752609B2 JP5752609B2 (ja) 2015-07-22

Family

ID=42116034

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011551028A Active JP5752609B2 (ja) 2009-02-19 2010-02-19 リポペプチドを精製する方法

Country Status (21)

Country Link
US (1) US9150894B2 (enExample)
EP (1) EP2398817B2 (enExample)
JP (1) JP5752609B2 (enExample)
KR (1) KR101666144B1 (enExample)
CN (1) CN102325785B (enExample)
AU (1) AU2010216475B2 (enExample)
BR (1) BRPI1008300B1 (enExample)
CA (1) CA2748932C (enExample)
DK (1) DK2398817T4 (enExample)
ES (1) ES2543457T5 (enExample)
HR (1) HRP20150761T4 (enExample)
HU (1) HUE026818T2 (enExample)
IL (1) IL214374A (enExample)
MX (1) MX2011008621A (enExample)
PL (1) PL2398817T5 (enExample)
PT (1) PT2398817E (enExample)
RU (1) RU2526391C2 (enExample)
SI (1) SI2398817T2 (enExample)
UA (1) UA105785C2 (enExample)
WO (1) WO2010095953A1 (enExample)
ZA (1) ZA201104848B (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2526391C2 (ru) 2009-02-19 2014-08-20 Кселлия Фармасьютикалз Апс Способ очистки липопептидов
CN102690329B (zh) * 2011-03-25 2014-06-04 杭州九源基因工程有限公司 一种戈舍瑞林多肽的纯化生产方法
CN102875652A (zh) * 2011-07-13 2013-01-16 北大方正集团有限公司 一种分离纯化达托霉素的方法
CN103159829B (zh) * 2011-12-08 2014-11-05 北大方正集团有限公司 达托霉素的提取方法
CN102675426B (zh) * 2012-04-26 2013-12-11 杭州华东医药集团生物工程研究所有限公司 一种达托霉素的提取纯化方法
CN102924572B (zh) * 2012-11-12 2014-12-03 华北制药集团新药研究开发有限责任公司 一种高纯度达托霉素的制备方法
CN104387444B (zh) * 2014-11-13 2017-12-08 北大医药重庆大新药业股份有限公司 一种达托霉素杂质rs‑2高纯度样品的制备方法
EP3233230B1 (en) * 2014-12-15 2024-06-12 Merck Patent GmbH Target molecule capture from crude solutions
CN105001305A (zh) * 2015-04-29 2015-10-28 利穗科技(苏州)有限公司 利用层析技术提取高纯度达托霉素的方法
CN105481950B (zh) * 2016-01-28 2019-01-04 丽珠集团福州福兴医药有限公司 一种达托霉素提取方法
IT201600127655A1 (it) 2016-12-16 2018-06-16 Gnosis Spa Processo per la purificazione di antibiotici lipopolipeptidici
CN108250270A (zh) * 2016-12-29 2018-07-06 天津领世生物科技开发有限公司 一种从发酵液中富集提取达托霉素的方法
CN112979756B (zh) * 2019-12-13 2023-01-03 浙江昌海制药有限公司 达托霉素的提纯方法
CN113004373B (zh) * 2019-12-19 2024-08-13 鲁南制药集团股份有限公司 一种达托霉素的纯化方法
RU2762182C1 (ru) * 2020-12-08 2021-12-16 Федеральное государственное бюджетное научное учреждение "Научно-исследовательский институт по изысканию новых антибиотиков имени Г.Ф. Гаузе" Гауземицины А и В - гликолипопептидные антибактериальные антибиотики и способ их получения
CN113340691B (zh) * 2021-06-05 2023-12-12 清华大学 一种提取海洋沉积物中不同赋存形态磷的方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4537717A (en) 1982-05-21 1985-08-27 Eli Lilly And Company Derivatives of A-21978C cyclic peptides
US4885243A (en) 1984-10-09 1989-12-05 Eli Lilly And Company Process for producing A-21978C derivatives
US4667016A (en) 1985-06-20 1987-05-19 Kirin-Amgen, Inc. Erythropoietin purification
ZA883887B (en) 1987-06-10 1990-02-28 Lilly Co Eli Chromatographic purification process
US4874843A (en) 1987-12-03 1989-10-17 Eli Lilly And Company Chromatographic purification process
JP2661790B2 (ja) * 1990-11-27 1997-10-08 電気化学工業株式会社 入尿トリプシンインヒビターの精製方法
ZA946122B (en) * 1993-08-17 1995-03-20 Amgen Inc Erythropoietin analogs
US5650496A (en) 1995-04-14 1997-07-22 Cephalon, Inc. IGF-I purification process
US6696412B1 (en) * 2000-01-20 2004-02-24 Cubist Pharmaceuticals, Inc. High purity lipopeptides, Lipopeptide micelles and processes for preparing same
AU2002246688A1 (en) * 2000-12-18 2002-07-30 Altus Biologics Inc. Methods for preparing purified daptomycin
US20060014674A1 (en) 2000-12-18 2006-01-19 Dennis Keith Methods for preparing purified lipopeptides
JP2010505874A (ja) * 2006-10-03 2010-02-25 ノヴォ ノルディスク アー/エス ポリペプチドコンジュゲートの精製方法
WO2009144739A1 (en) * 2008-05-26 2009-12-03 Biocon Limited Amorphous daptomycin and a method of purification thereof
RU2526391C2 (ru) 2009-02-19 2014-08-20 Кселлия Фармасьютикалз Апс Способ очистки липопептидов
CN101899094B (zh) * 2009-06-01 2012-11-21 安徽丰原发酵技术工程研究有限公司 一种高纯达托霉素的制备方法

Similar Documents

Publication Publication Date Title
JP2012518034A5 (enExample)
NZ597809A (en) Method to improve virus removal in protein purification
WO2013101743A3 (en) Microorganism nucelic acid purification from host samples
WO2013078170A8 (en) Purification of anti-c-met antibodies
HRP20150761T4 (hr) Postupak za pročišćavanje lipopeptida
WO2010048190A3 (en) Antibodies that bind to il-12 and methods of purifying the same
MY161596A (en) An anti-cancer active substance from antrodia camphorata, method for preparing the same and use thereof
JP2011177709A5 (enExample)
JP2012502876A5 (enExample)
JP2008290071A5 (enExample)
WO2014178078A3 (en) Novel cloning, expression & purification method for the preparation of ranibizumab
WO2012066059A3 (de) Verfahren zur biokatalytischen cyclisierung von terpenen und darin einsetzbare cyclase-mutanten
JP2013522399A5 (enExample)
JP2017516475A5 (enExample)
JP2013511566A5 (enExample)
HK1207397A1 (en) Purification of succinic acid
JP2010509477A5 (enExample)
WO2007130535A3 (en) Novel protein fusion/tag technology
WO2010002165A3 (ko) 필터링 기술을 이용한 조 글리세린의 정제방법
MX2020000224A (es) Purificacion de polisacárido para la produccion de vacuna utilizando enzimas líticas, filtración de flujo tangencial y cromatografía multimodal.
NZ609370A (en) Synthetic gene for expressing sm-14 in pichia pastoris, methods for producing and purifying sm-14 and the use thereof as a vaccine and diagnostic medium
WO2009088255A3 (en) Method for preparing antigen effective for preventing anthrax infection
Lv et al. Chemical constituents from dried sorophore of cultured Cordyceps militaris
WO2014010921A3 (ko) 겔형 육수 조성물 및 그 제조 방법
WO2013190453A3 (en) Compositions for separation methods